Quinolines that modulate SERCA and their use for treating disease
US11730729B2 · kind B2 · utility
1Cited by
11References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 13, 2021 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Aug 13, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.